Klaipėdos Miesto poliklinika
- Address
- Taikos pr. 76, 93200 Klaipėda, Lithuania
Klaipėdos Miesto poliklinika - Gastroenterology Research
Klaipėdos Miesto poliklinika is actively engaged in clinical research focused on inflammatory bowel diseases and gastrointestinal disorders. The center contributes to international efforts in advancing therapeutic options for patients with chronic intestinal conditions, with particular emphasis on evaluating novel biologic therapies.
- Ulcerative colitis long-term treatment studies
- Biologic therapy evaluation and safety monitoring
- Inflammatory bowel disease management
The facility participates in extension studies that assess the long-term efficacy and safety of innovative treatments, including mirikizumab for patients with ulcerative colitis. Through these clinical trials, the center helps gather critical evidence on sustained therapeutic responses and contributes to understanding optimal maintenance strategies for patients with chronic gastrointestinal inflammatory conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Eli Lilly & Co.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Eli Lilly & Co.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 79 other sites in Lithuania
Therapeutic Area Benchmark — Lithuania
Select a therapeutic area to compare against other sites in Lithuania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Lithuania
Market Share
Country: Lithuania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Klaipėdos Miesto poliklinika
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Long-Term Efficacy and Safety Evaluation of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis: A Phase 3, Multicenter, Open-Label Extension Study | Eli Lilly & Co. | Phase III | Not Recruiting | Sep 2018 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Mirikizumab | 1 | Unknown | 2018-09-13 | 2018-09-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.